The transformative potential is evident in specific contexts: for patients with high cardiovascular risk, substantial obesity, and access to comprehensive care, including nutritional support, GLP-1 agonists offer unprecedented therapeutic benefits
Biermanns study found that most people who halved the dosing frequency of a GLP-1 medication maintained their weight loss and improvements in blood sugar, cholesterol, and blood pressure
These are all carbohydrate-dominant foods
"Mine is a different one than people assume, but I ended up having to do that too because my bloodwork got so bad, Clarkson admitted
They support the concept of additive benefit from using GIP and GLP-1 RAs in combination
If I could only add one peptide to a Retatrutide protocol, BPC-157 would be my choice